Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Samsung BioLogics
Pharma
Eisai, Sumitomo, Kyowa Kirin and more—Fierce Pharma Asia
Eisai presented updated projections for Leqembi. Sumitomo plans to lay off 400 U.S. staffers. Plus more.
Angus Liu
Mar 8, 2024 9:42am
Samsung Biologics expands UCB partnership with new $288M deal
Mar 7, 2024 10:00am
Leqembi, Takeda, Roche—Fierce Pharma Asia
Feb 9, 2024 9:02am
Samsung Biologics, LegoChem link to propel ADC development
Feb 7, 2024 10:16am
Lonza closes plant in China but has a turnaround quarter
Jan 26, 2024 3:11pm
Carvykti, AstraZeneca, Samsung—Fierce Pharma Asia
Jan 26, 2024 11:08am